VACBF (Nykode Therapeutics AS) Total Stockholders Equity : $136.21 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Total Stockholders Equity?

Nykode Therapeutics AS's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $136.21 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nykode Therapeutics AS's Book Value per Share for the quarter that ended in Dec. 2024 was $0.42. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nykode Therapeutics AS's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.03.

Nykode Therapeutics AS Total Stockholders Equity Historical Data

The historical data trend for Nykode Therapeutics AS's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Total Stockholders Equity Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

178.85

194.06

157.02

171.26

136.21

Nykode Therapeutics AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															171.26	158.72	152.08	142.64	136.21

Nykode Therapeutics AS (OTCPK:VACBF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nykode Therapeutics AS's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(136.214	-	0)	/	326.546
	=	0.42

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nykode Therapeutics AS's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.293	+	2.145)	/	136.214
	=	0.03

Nykode Therapeutics AS Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NYKD:Norway 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.